How Long Is a Port Left In After Chemo?

Most ports stay in place for months to years after the last chemotherapy infusion, and the timing of removal depends more on your cancer type and recurrence risk than on whether active treatment has ended. A retrospective study of 376 breast cancer patients found a median port indwelling time of 464 days, with some ports remaining functional for over seven years. Many oncologists prefer to leave the port in for at least a year or two after finishing chemo, partly because if cancer returns, you would need venous access again and removing the port too early means another surgical procedure to put one back in.

Why Your Oncologist May Not Rush to Remove It

The decision to remove a port is rarely urgent. Ports are designed for long-term use and, when maintained properly, can sit quietly under your skin without causing problems. The main reason doctors wait is the possibility of recurrence. If your cancer comes back within the first couple of years, you will almost certainly need IV access for additional treatment. Having the port already in place saves you a second implantation surgery, another round of anesthesia, and the associated costs and risks. This is especially true for cancers with higher early recurrence rates, where the first two years after treatment carry the most uncertainty.

A large analysis of breast cancer patients illustrates the tradeoff clearly. Patients whose ports were removed within two years had a much higher rate of needing a second catheter placed afterward, around 29%, compared to roughly 4% of patients who kept the port beyond two years. They also had more unplanned port removals due to complications during that early window. The researchers concluded that for breast cancer patients who no longer need regular intravenous medication, removal after two years strikes a reasonable balance between avoiding unnecessary device maintenance and being prepared if treatment resumes.¹

That two-year mark is not a universal rule. It comes from data on breast cancer specifically. For other cancers with different recurrence timelines, your oncologist may suggest keeping or removing the port on a different schedule. The conversation should be specific to your diagnosis, your treatment history, and whether any ongoing therapies like immunotherapy or maintenance drugs require IV access.

What Maintenance Looks Like While You Wait

A port that is not being used for active treatment still needs periodic flushing to keep blood from clotting inside the catheter. Manufacturers typically recommend a flush every four weeks. For many people who have finished chemo, this means a trip to the clinic once a month just to have a nurse access the port, push saline or heparin through it, and send you home. It takes about ten minutes, but the scheduling, travel, and copays add up over months and years.

The good news is that the evidence supports stretching those intervals out considerably. A systematic review and meta-analysis found that extending the flush interval beyond four weeks is safe and that going as long as eight weeks did not increase the rate of catheter blockages or other complications.² Other research has pushed the boundary even further. A study in patients with colorectal cancer demonstrated that flushing every three months was safe and practical, and it aligned neatly with their routine surveillance visits so they did not need extra trips.³ A phase II trial reached the same conclusion: flushing every three months was safe, effective, and more likely to keep patients compliant because the schedule was less burdensome.⁴

A larger study in JCO Oncology Practice confirmed that extending maintenance flushes to 12 weeks did not increase the rate of port-related adverse events.⁵ Despite all this evidence, many clinics still default to monthly flushes because that is what the device manufacturers recommend and what institutional policies have not yet updated. If you are finding monthly visits inconvenient, it is worth asking your care team whether a longer interval is appropriate for you. Not every clinic will agree, but the data is on your side.

Does It Matter Whether They Flush With Heparin or Saline?

Traditionally, ports were flushed and locked with a heparin solution to prevent clotting. That protocol has been questioned in recent years because heparin carries a small risk of side effects, including heparin-induced thrombocytopenia, and because plain saline is simpler and cheaper. A systematic review and meta-analysis concluded that normal saline can safely replace heparin at concentrations of 50 or 100 units per milliliter for maintaining port patency.⁶

A randomized trial comparing the two found no differences in rates of infection, blood clots, or catheter blockage whether patients received saline every two months or heparin every four months, compared to the standard heparin every two months.⁷ Another comparison study found essentially the same blockage rates in both the heparin and saline groups.⁸ If your clinic is still using heparin and you are making these maintenance visits for months or years post-chemo, you can ask whether switching to saline is an option. For many patients, it simplifies one small part of an already cumbersome routine.

Complications That Can Develop Over Time

Ports are generally reliable devices, but they are not without risks, and those risks accumulate the longer the port stays in. The most common long-term concern is blood clot formation around the catheter. A review of the literature found catheter-related clot complications at rates ranging widely from 12% to 64% across retrospective studies, depending on how aggressively the studies looked for them.⁹ Many of these clots are clinically silent, meaning they show up on imaging but do not cause symptoms. When they do cause symptoms, you might notice swelling in the arm or neck on the side of the port, or the port may stop drawing blood properly.

Another common issue is the formation of a fibrin sheath, a thin sleeve of protein that grows around the catheter tip and can interfere with blood withdrawal or infusion flow. One study found that port dysfunction from fibrin sheaths occurred at a median of about four months after implantation, though it could happen as early as a week or as late as over two years.¹⁰ This does not always mean the port needs to come out. A clot-dissolving drug can often be injected through the port to restore function, which is usually done as a quick outpatient procedure.

Infection is the other major concern, though it is more common during active treatment when the port is accessed frequently and the patient’s immune system is suppressed. Once chemotherapy is over and the port is being accessed only for maintenance flushes, the infection risk drops. Still, any time a needle goes through your skin into the port, there is a small chance of introducing bacteria. This is one of the arguments for extending flush intervals when possible: fewer needle sticks mean fewer opportunities for infection.

Using the Port for Scans and Other Purposes

One practical reason to keep a port after finishing chemo is that it can serve other medical purposes during the surveillance period. If you need contrast-enhanced CT scans to monitor for recurrence, and if your port is rated for power injection, it can be used instead of starting a new IV each time. A study of 119 contrast injections through ports found no complications and comparable image quality to scans done through a standard peripheral IV.¹¹

Another study tracked 676 CT scans in patients with ports and found zero cases of contrast leaking outside the vein or device failure during any scan where the port was used for injection.¹² For patients with difficult veins, which is common after multiple rounds of chemotherapy, having the port available for scans can be a genuine quality-of-life benefit. Not all ports are rated for the high-pressure injection that CT contrast requires, so check with your team about whether yours is compatible. Ports specifically labeled as “power-injectable” are designed for this use.

Ports in Children

The timeline looks different in pediatric oncology. Children’s treatment protocols are often shorter and more intensive, and the decision to remove a port is shaped by growth, activity level, and the emotional toll of having a device implanted. A pediatric study found an average port indwelling time of about 291 days, considerably shorter than the adult breast cancer data. Unplanned removal due to complications was needed in about 13% of cases, most often because of infection.¹³

In another pediatric analysis, the most common reason for port removal was simply that treatment was done, accounting for about 60% of removals. Infection led to removal in about 15% of cases, and death from the underlying disease with the port still in place accounted for a similar fraction.¹⁴ Pediatric oncologists tend to lean toward earlier removal once treatment is complete, partly because children are more physically active and partly because the psychological burden of the device can weigh on both the child and their parents.

The Emotional Side of Keeping a Port

Something that does not show up in complication-rate data is how it feels to walk around with a port after treatment ends. For many survivors, the port is a physical reminder of cancer that they carry under their skin. A qualitative study exploring the psychological experiences of patients with implanted ports captured this sentiment directly, with one patient expressing a “phobia about the infusion port” and hoping to have it removed as soon as chemotherapy was over.¹⁵

This is a legitimate consideration, and it deserves weight in the removal conversation. The medical rationale for keeping the port, reducing the chance of needing reimplantation, is real. But so is the psychological cost of living with a device that anchors you to a chapter of your life you want to move past. Some people are unbothered; others find the port distressing every time they catch a glimpse of it in the mirror or feel it when they roll over in bed. There is no right answer, and neither the clinical data nor your oncologist can tell you how much that emotional weight matters relative to the medical benefit.

When Removal Itself Gets Complicated

Port removal is typically a minor outpatient procedure done under local anesthesia. It takes about 30 minutes, and most people go home the same day with a small incision that heals within a couple of weeks. But the longer a port stays in, the more the body’s tissues can grow around the catheter, making removal slightly more involved. In rare cases, the catheter becomes firmly adhered to the vessel wall or surrounding tissue. Forceful pulling in these situations risks vascular injury or breaking the catheter, which would leave a fragment inside a blood vessel. When adhesions are suspected, surgeons may use a guide wire technique to safely free the catheter rather than simply pulling it out.¹⁶

These complications are uncommon, and most removals are straightforward. But it is worth knowing that the procedure is not quite as trivial as it sounds if the port has been in place for several years. If you are at the point where your oncologist is comfortable with removal, there is no medical advantage to waiting longer. Delaying beyond the point of clinical need only increases the chance of tissue growth complicating the eventual extraction.

How Much Say You Actually Get in the Decision

In theory, port removal is a shared decision between you and your oncologist. In practice, patient preference does not always drive the conversation. A survey of oncology clinicians found that while they identified patient preference as the most influential factor in choosing a central venous access device, only about 28% said they almost always considered patient preference when making their recommendation. Another quarter said they often did, a quarter said sometimes, and roughly a fifth said they rarely or never factored in what the patient wanted. The reasons included logistical constraints, hospital guidelines, and a strong clinician preference for a particular device based on effectiveness or safety.¹⁷

That survey was specifically about the choice of device for treatment, but the same dynamic can carry over to removal decisions. If you want the port out and your oncologist wants to wait, push for a concrete explanation of what scenario they are guarding against and how likely it is. If the recurrence risk for your specific cancer drops substantially after a certain time point, that is useful information that can ground the conversation. If the answer is “we just like to wait,” that is a softer basis and gives you room to advocate for what you want.

Ports Versus Other Central Lines

If you are wondering why you got a port in the first place instead of a PICC line or tunneled catheter, the answer usually comes down to how long treatment is expected to last and how much the device will interfere with daily life. Ports sit entirely beneath the skin when not in use, so there is nothing external to maintain or protect between infusions. A retrospective analysis comparing ports and PICCs in breast cancer patients found that PICCs had a significantly higher rate of major complications, with roughly 11% experiencing serious problems compared to about 5% in the port group.¹⁸

PICCs are easier to place and remove and do not require a surgical procedure, which makes them a reasonable choice for shorter treatment courses. But for regimens lasting several months and for patients who may need IV access well beyond active treatment, ports have clear durability advantages. They are also more compatible with an active lifestyle once the incision heals, because there is no external tubing to worry about during showers, swimming, or exercise. If you are facing a choice between the two, the expected duration and intensity of treatment are the biggest factors.

What a Port Costs Over Time

The financial side of port ownership is worth mentioning because it rarely comes up in clinical conversations. A prospective study tracking 333 ports over at least six months found that the total cost per patient for that period, covering the device itself, implantation, complication management, and maintenance, came to about $1,970.¹⁹ That figure is from an older study and will vary dramatically by country and insurance coverage, but the principle holds: there are ongoing costs for a device you are no longer actively using. Each maintenance flush visit carries a facility fee, a nursing charge, and supply costs. Over a year or two of post-chemo maintenance, those visits add up, especially if you are going monthly rather than every three months.

The breast cancer analysis noted that patients who kept their ports less than two years actually had higher daily costs because of the greater rate of unplanned removals and secondary catheter placements.¹ In other words, removing a port too early and then needing another one costs more than simply maintaining the original port for two years. But keeping a port in indefinitely beyond the point of clinical usefulness is not free either. The sweet spot, for both cost and complication risk, seems to land somewhere around the two-year mark for cancers with a meaningful early recurrence window, with the flexibility to adjust based on your individual situation.